SCHEMBL5794633

SCHEMBL5794633

O=Cc1ccc(C(=O)OCC(F)(F)F)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.53
ADRB2 P07550 1/20 0.50
ADRB1 P08588 1/20 0.50
ADRB3 P13945 1/20 0.50
MAPK1 P28482 1/20 0.44
HIF1A Q16665 1/20 0.44
PARP10 Q53GL7 1/20 0.41
PARP3 Q9Y6F1 1/20 0.41
JMJD6 Q6NYC1 1/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
XBP1 P17861 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
LMNA P02545 1/20 0.39
POLB P06746 1/20 0.39
KMT2A Q03164 2/20 0.38
KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1496824 0.87 MAPK1 (0.55) ALDH1A1MAPK1HIF1AJMJD6NPC1
SCHEMBL4378876 0.85 MAPK1 (0.43) ALDH1A1ADRB2ADRB1ADRB3MAPK1
SCHEMBL5972510 0.82 ALDH1A1 (0.49) ALDH1A1ADRB2ADRB1ADRB3MAPK1
SCHEMBL19219008 0.81 ALDH1A1 (0.56) ALDH1A1ADRB2ADRB1ADRB3MAPK1
SCHEMBL7945129 0.80 ESR1 (0.58) ALDH1A1ADRB2ADRB1ADRB3MAPK1
SCHEMBL9244575 0.80 ADRB2 (0.49) ALDH1A1ADRB2ADRB1ADRB3MAPK1
SCHEMBL19219012 0.80 ALDH1A1 (0.54) ALDH1A1ADRB2ADRB1ADRB3MAPK1
SCHEMBL19219007 0.80 ALDH1A1 (0.62) ALDH1A1ADRB2ADRB1ADRB3MAPK1
SCHEMBL9247387 0.79 GAA (0.49) ALDH1A1MAPK1HIF1AJMJD6NPC1
SCHEMBL21510512 0.79 KMT2A (0.48) ALDH1A1PARP10PARP3NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003057896-A1 METHODS FOR PREPARING ANTHRACYCLINONE DERIVATIVES AND ANTHRACYCLINONE DERIVATIVES PER SE ALBANY MOLECULAR RESEARCH, INC. (US) 2003-07-17 WO claimed
WO-2003057687-A1 METHODS FOR PREPARING DOXORUBICIN DERIVATIVES ALBANY MOLECULAR RESEARCH, INC. (US) 2003-07-17 WO claimed
WO-2006012277-A2 BIOCATALYTIC PROCESS FOR PREPARING ENANTIOMERICALLY ENRICHED PRAMIPEXOLE AMR TECHNOLOGY, INC. (US) 2006-02-02 WO disclosed
WO-2003057687-A1 METHODS FOR PREPARING DOXORUBICIN DERIVATIVES ALBANY MOLECULAR RESEARCH, INC. (US) 2003-07-17 WO disclosed
WO-2003057896-A1 METHODS FOR PREPARING ANTHRACYCLINONE DERIVATIVES AND ANTHRACYCLINONE DERIVATIVES PER SE ALBANY MOLECULAR RESEARCH, INC. (US) 2003-07-17 WO disclosed